Sonelokimab
Product Specifications
CAS Number
1414386-05-2
Target
Interleukin|||MMP
Related Pathways
Proteases/Proteasome|||Immunology/Inflammation
Bioactivity
Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody combining monovalent camelid-derived nanobodies targeting human interleukin (IL) -17A and IL-17F with human serum albumin VHHs, presenting it as a promising candidate for investigating plaque-type psoriasis treatments [1] [2].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15400126 1 Vial
Lentiviral human TFCP2L1 sgRNA gene knockout kit - Lentiviral human TFCP2L1 sgRNA gene knockout kit (100)
Ask
View Details VP 776-8-45 1 EACH
STIR ELEMENT, OVAL, AlNiCo Magnet, 5.5MGO, Encapsulated with Isostatically Molded, FDA Approved, Pure PTFE, 8.0mm Diameter, 45.0mm Length, 260°C Max Operating Temp for Coating
Ask
View Details 
124364-FITC 100 µL
CASQ1 (Calsequestrin-1, Calmitin, Calsequestrin, Skeletal Muscle Isoform, CASQ) (FITC)
Ask
View Details